NFG
AEGR

Next Financial Group’s Aegerion Pharmaceuticals AEGR Stock Holding History

Next Financial Group’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-100
Closed – – 2574
2016
Q3 		$0 Buy
+100
New +$173 ﹤0.01% 2500
2016
Q2 		– Sell
-50
Closed – – 1925
2016
Q1 		$0 Sell
50
-50
-50% -$310 ﹤0.01% 1956
2015
Q4 		$1K Hold
100
– – ﹤0.01% 1747
2015
Q3 		$1K Hold
100
– – ﹤0.01% 1788
2015
Q2 		$1K Hold
100
– – ﹤0.01% 1817
2015
Q1 		$2K Sell
100
-50
-33% -$1.27K ﹤0.01% 1741
2014
Q4 		$3K Sell
150
-700
-82% -$17.6K ﹤0.01% 1690
2014
Q3 		$28K Hold
850
– – 0.01% 1234
2014
Q2 		$27K Buy
+850
New +$31.7K 0.01% 507

Next Financial Group's AEGR Position: Q4 2016 in Review

Next Financial Group sold out of Aegerion Pharmaceuticals (AEGR) in Q4 2016, closing a stake of 100 shares.

Next Financial Group first reported a position in AEGR in Q2 2014 and held it in 9 quarters. The position peaked at $28K in Q3 2014. 0 funds tracked by Wall St. Rank hold AEGR as of Q4 2016.

  • Next Financial Group reported no remaining Aegerion Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Next Financial Group sold 100 Aegerion Pharmaceuticals shares in Q4 2016.
  • Next Financial Group first reported a position in Aegerion Pharmaceuticals in Q2 2014 and held it in 9 quarters.
  • Next Financial Group's Aegerion Pharmaceuticals position peaked at $28K in Q3 2014.
  • 0 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2016.

Based on Next Financial Group's 13F filing for Q4 2016, filed 2 Feb 2017.